NEW YORK --(BUSINESS WIRE)--
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the launch of its AppConnect Partner Program in support of mobile health (mHealth) innovation. The program combines Medidata’s cloud and mHealth technology with access to digital health firms that have extensive experience developing patient engagement tools for clinical development, such as mobile apps and remote patient research platforms.
Boston Technology Corporation, LifeMap Solutions and THREAD—whose work and client-base spans across regions and multiple therapeutic areas, and includes apps such as MIT VoiceUp, Asthma Health and EpiWatch, respectively—are the first companies to be certified as AppConnect partners.
“These partnerships are a critical piece of our ongoing effort to make it easier for life sciences companies to bring mobile health tools into the highly structured world of clinical trials,” said Kara Dennis, Medidata’s managing director of mHealth. “The rapidly expanding ecosystem of mobile health technologies requires openness and interoperability, and we want to ensure our clients have access to powerful mobile capabilities that improve both scientific programs and patient experiences.”
Since the launch of Apple® ResearchKitTM, clinical trial sponsors have been increasingly interested in incorporating mHealth technology into their research programs. Medidata is at the forefront of this adoption curve, enabling sponsors to successfully instrument patients, collect a wide variety of objective and patient-reported data, and integrate this information with other clinical data. The AppConnect Partner Program, unveiled today at Medidata Symposium in Phoenix, will further those efforts by creating an ecosystem that allows life sciences companies to gather and analyze data collected in a myriad of different ways between patient visits to a clinical trial site.
“In moving digital health innovation forward to change the way we conduct clinical research, trial sponsors are looking for their remote patient research models to provide the highest levels of data privacy, process rigor and storage. Medidata has played a pivotal role in this important shift, creating the infrastructure and a roadmap to help guide the life sciences industry into what happens next,” said John Reites, chief product officer and partner at THREAD. “We’re really excited to be partnering with a like-minded pioneer in this space such as Medidata, helping our joint customers adopt mobile health innovation to change the way they conduct research and engage their patients.”
Medidata AppConnect, a software development kit (SDK) that is part of Medidata Patient Cloud®, provides the flexibility to gather and process a wide range of data from nearly any type of mobile application. AppConnect partners have the capabilities and industry expertise to build mobile apps and remote patient research programs for clinical trials that collect data from patients and pull it directly into the regulatory-compliant, secure environment of the Medidata Clinical Cloud® platform.
“As the first commercial developer spotlighted in Apple’s ResearchKit launch, we’ve seen firsthand how the mHealth revolution has helped research studies transcend traditional brick-and-mortar limitations,” said Corey Bridges, CEO of LifeMap Solutions. “Thanks to Medidata, that revolution now hits its next big milestone: merging the innovation and flexibility of the Internet with the power of the Medidata Clinical Cloud. As a result, life sciences companies can reduce clinical development costs and risks, and deliver new drugs and devices to the market faster than ever before.”
Shyam Deval, president of Boston Technology Corporation, added: “Our partnership with Medidata is truly going to deepen our capabilities and help create tangible value for our clients. Mobile solutions are paving the way for enhanced patient experiences and engagement, improved adherence, better data capture, and smarter analysis and insights. With Medidata’s industry-leading platform and advanced mHealth technology, we can now create compelling solutions to increase the efficiency and productivity of clinical trials conducted worldwide.”
Executives from Boston Technology Corporation, LifeMap Solutions and THREAD are participating in Medidata Symposium, which runs from October 17-19, 2016. The annual conference provides Medidata clients and service partners with opportunities to learn and share best practices for the effective design, planning, execution, management and reporting of clinical studies using the Medidata platform. AppConnect partners will participate in a panel discussion on trends in patient engagement and best practices for developing apps and other mHealth solutions for clinical research.
About Boston Technology
Boston Technology Corporation, a Boston based digital health technology services company provides mobile and web solution development for secure patient experience and engagement, medical and clinical research and IoT Human Interface applications. Please visit our case studies page at http://www.boston-technology.com/case-studies for more information on applications developed by BTC for major biotech companies, universities and hospitals.
About LifeMap Solutions
LifeMap Solutions develops innovative digital health solutions with world-class medical, research, and commercial institutions. From apps for research and clinical care to EMR-supporting middleware and an app development platform, LifeMap's products empower users to better understand and manage their health and researchers and care providers to reach and serve larger audiences. LifeMap Solutions is a subsidiary of BioTime, Inc. (NYSE MKT:BTX), and is headquartered in San Jose, California. For more information, please visit www.lifemap-solutions.com.
THREAD is a digital health platform enabling remote patient research and care by healthcare providers, pharmaceutical companies and contract research organizations (CROs) via Apple ResearchKit, CareKit and more. THREAD pioneered remote patient research and care with 4 of the first 8 ResearchKit studies including EpiWatch for Johns Hopkins University, The PRIDE Study for UCSF and contributions to mPower for Sage Bionetworks and Mole Mapper for OHSU. For more information, visit www.THREADResearch.com.
About Medidata Patient Cloud
Medidata Patient Cloud® is a comprehensive and regulatory-compliant mobile health solution that accelerates patient-centric clinical research. Patient Cloud enables sponsors to use sensors and apps that capture a richer, more complete dataset directly from the patient, improving the clinical trial experience on the Medidata Clinical Cloud. The suite of solutions includes Sensor Link, a data ingestion platform for biosensors and wearables; AppConnect, an SDK built to integrate apps within the Medidata Clinical Cloud; and ePRo, a mobile app that collects responses to patient questionnaires and diaries.
Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including more than 700 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.
Connect with Medidata
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata welcomes inaugural #AppConnect partners: @BostonTechCorp, @THREADresearch & @LifeMapSolution http://ow.ly/cGLn305gYEn #MedidataSYM
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.